Metraipolis › archive › dc_0ef70d498d52

ADVANTAGE: Advanced discovery of visceral analgesics by neuroimmune targets and the genetics of extreme human phenotype, a study protocol — Europe PMC PMID:42166469

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42166469
DOI
10.1371/journal.pone.0350169
License (as archived)
solo-consultazione
Archived
2026-10-10T00:01:49.490Z
SHA-256 of the archived text
cf120fdabd17081dd9b44d44765717ed71de7154db6b080a1c07ce5ecd877f8f
Stable URL of this page
https://metraipolis.com/documento/dc_0ef70d498d52

How to cite

ADVANTAGE: Advanced discovery of visceral analgesics by neuroimmune targets and the genetics of extreme human phenotype, a study protocol — Europe PMC PMID:42166469 — Europe PMC (en), https://europepmc.org/article/MED/42166469 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0ef70d498d52 (Metraipolis archive dc_0ef70d498d52, sha256 cf120fdabd17081dd9b44d44765717ed71de7154db6b080a1c07ce5ecd877f8f)
BibTeX
@misc{dc0ef70d498d52,
  title = {ADVANTAGE: Advanced discovery of visceral analgesics by neuroimmune targets and the genetics of extreme human phenotype, a study protocol — Europe PMC PMID:42166469},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42166469},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0ef70d498d52; sha256 cf120fdabd17081dd9b44d44765717ed71de7154db6b080a1c07ce5ecd877f8f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42166469. Agents can read the archived copy with the MCP tool read_document.